Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oxidoreductases acting on CH-NH group donors are enzymes classified under EC 1.5 in the Enzyme Commission numbering system[1][3][5]. They catalyze oxidation-reduction (redox) reactions in which a substrate containing a CH-NH group (such as a secondary amine) acts as a hydrogen or electron donor and generates a C=N double bond as the primary product[6][8]. This class is diverse, covering dehydrogenases that act on various substrates and use different physiological acceptors including NAD(+), NADP(+), oxygen, disulfides, flavins, quinones, or iron-sulfur proteins[2][5]. EC 1.5 oxidoreductases play important roles in intermediary metabolism, amino acid catabolism, product detoxification, cell signaling, and neurotransmitter regulation. Individual enzymes in this class (such as monoamine oxidase or sarcosine dehydrogenase) are drug targets and studied for their role in diseases, but the EC 1.5 group itself refers to a mechanistic class rather than a single molecular entity[1][3][6].
Inhibition or modulation of redox enzymatic activity; Alteration of substrate dehydrogenation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxidoreductase acting on CH-NH group donor.